-
Past work: Key lead in the tech transfer of three FDA IND-approved RNA LNP drug products: Covid-vaccine, shingle vaccine, and a cancer drug product; Developed LNP manufacturing process and generate preclinical data for tissue-targeting and enhanced LNPs;
-
L. Feng et al. , mRNA Vaccines Encoding Influenza Virus Hemagglutinin (HA) Elicits Immunity in Mice from Influenza A Virus Challenge, bioRxiv, 2023.11.15.566914; doi: https://doi.org/10.1101/2023.11.15.566914
-
X Cheng, et al, Modulation of Immune Response to Chlamydia muridarum by Host miR-135a, Frontiers in Cellular and Infection, April 2021, Volume 11.
-
Feng Cao, Cheng X, liposomal troponoid compound formulations, WO2021041776A1, 2021, International Patent Application No. PCT/US2020/048358
-
Cheng X, Mustoe TA, Galiano RD, Hong SJ, Xie P, Jia SX. A liposomal statin formulation. United States Patent No US10716758B2, 2018.
-
Ping X, Dolivo D., Jia S.X; Cheng X, Salcido J.; Galiano, R; Hong S; Mustoe T. Liposome‐encapsulated statins reduce hypertrophic scarring through topical application, Wound Repair and Regeneration, 2020, 28(4), Pages 460-469
-
Cheng X, Carson K, Mcdonough J, Gourapura RG, Lee CW, Dhakal S, inventors; A liposomal subunit flu vaccine formulation, 2019. U.S. Patent Award No. 10,478,488.
-
Dhakal, S., Cheng, X., Salcido, J., Renu, S., Bondra, K., Lakshmanappa, Y. S., . . . Renukaradhya, G. J. (2018). Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs. Int J Nanomedicine, 13, 6699-6715. doi:10.2147/ijn.s178809